BACKGROUND: Genetic studies reveal that vpu is one of the most variable regions in HIV-1 genome. Functional studies have been carried out mostly with Vpu derived from laboratory adapted subtype B pNL 4-3 virus. The rationale of this study was to characterize genetic variations that are present in the vpu gene from HIV-1 infected individuals from North-India (Punjab/Haryana) and determine their functional relevance. METHODS: Functionally intact vpu gene variants were PCR amplified from genomic DNA of HIV-1 infected individuals. These variants were then subjected to genetic analysis and unique representative variants were cloned under CMV promoter containing expression vector as well as into pNL 4-3 HIV-1 virus for intracellular expression studies. These variants were characterized with respect to their ability to promote virus release as well as cell death. RESULTS: Based on phylogenetic analysis and extensive polymorphisms with respect to consensus Vpu B and C, we were able to arbitrarily assign variants into two major groups (B and C). The group B variants always showed significantly higher virus release activity and exhibited moderate levels of cell death. On the other hand, group C variants displayed lower virus release activity but greater cell death potential. Interestingly, Vpu variants with a natural S61A mutation showed greater intracellular stability. These variants also exhibited significant reduction in their intracellular ubiquitination and caused greater virus release. Another group C variant that possessed a non-functional β-TrcP binding motif due to two critical serine residues (S52 and S56) being substituted with isoleucine residues, showed reduced virus release activity but modest cytotoxic activity. CONCLUSIONS: The natural variations exhibited by our Vpu variants involve extensive polymorphism characterized by substitution and deletions that contribute toward positive selection. We identified two major groups and an extremely rare β-TrcP binding motif mutant that show widely varying biological activities with potential implications for conferring subtype-specific pathogenesis.
BACKGROUND: Genetic studies reveal that vpu is one of the most variable regions in HIV-1 genome. Functional studies have been carried out mostly with Vpu derived from laboratory adapted subtype B pNL 4-3 virus. The rationale of this study was to characterize genetic variations that are present in the vpu gene from HIV-1 infected individuals from North-India (Punjab/Haryana) and determine their functional relevance. METHODS: Functionally intact vpu gene variants were PCR amplified from genomic DNA of HIV-1 infected individuals. These variants were then subjected to genetic analysis and unique representative variants were cloned under CMV promoter containing expression vector as well as into pNL 4-3 HIV-1 virus for intracellular expression studies. These variants were characterized with respect to their ability to promote virus release as well as cell death. RESULTS: Based on phylogenetic analysis and extensive polymorphisms with respect to consensus Vpu B and C, we were able to arbitrarily assign variants into two major groups (B and C). The group B variants always showed significantly higher virus release activity and exhibited moderate levels of cell death. On the other hand, group C variants displayed lower virus release activity but greater cell death potential. Interestingly, Vpu variants with a natural S61A mutation showed greater intracellular stability. These variants also exhibited significant reduction in their intracellular ubiquitination and caused greater virus release. Another group C variant that possessed a non-functional β-TrcP binding motif due to two critical serine residues (S52 and S56) being substituted with isoleucine residues, showed reduced virus release activity but modest cytotoxic activity. CONCLUSIONS: The natural variations exhibited by our Vpu variants involve extensive polymorphism characterized by substitution and deletions that contribute toward positive selection. We identified two major groups and an extremely rare β-TrcP binding motif mutant that show widely varying biological activities with potential implications for conferring subtype-specific pathogenesis.
Authors: Alyssa Cornall; Laveena Sharma; Ajantha Solomon; Paul R Gorry; Suzanne M Crowe; Paul U Cameron; Sharon R Lewin Journal: J Virol Methods Date: 2010-02-01 Impact factor: 2.014
Authors: Janet L Douglas; Kasinath Viswanathan; Matthew N McCarroll; Jean K Gustin; Klaus Früh; Ashlee V Moses Journal: J Virol Date: 2009-06-10 Impact factor: 5.103
Authors: M Sarah Hill; Autumn Ruiz; Erik Pacyniak; David M Pinson; Nathan Culley; Bonnie Yen; Scott W Wong; Edward B Stephens Journal: Virology Date: 2007-10-24 Impact factor: 3.616
Authors: Asa Rahimi; Gursev Anmole; Maribel Soto-Nava; Tania Escamilla-Gomez; Tristan Markle; Steven W Jin; Guinevere Q Lee; P Richard Harrigan; David R Bangsberg; Jeffrey Martin; Santiago Avila-Rios; Gustavo Reyes-Teran; Mark A Brockman; Zabrina L Brumme Journal: J Virol Methods Date: 2016-11-16 Impact factor: 2.014
Authors: Suzanne Pickering; Stephane Hué; Eun-Young Kim; Susheel Reddy; Steven M Wolinsky; Stuart J D Neil Journal: PLoS Pathog Date: 2014-01-23 Impact factor: 6.823
Authors: Zabrina L Brumme; Mark A Brockman; Gisele Umviligihozo; Kyle D Cobarrubias; Sandali Chandrarathna; Steven W Jin; Nicole Reddy; Helen Byakwaga; Conrad Muzoora; Mwebesa B Bwana; Guinevere Q Lee; Peter W Hunt; Jeff N Martin; Chanson J Brumme; David R Bangsberg; Etienne Karita; Susan Allen; Eric Hunter; Thumbi Ndung'u Journal: J Virol Date: 2020-07-01 Impact factor: 5.103
Authors: Larance Ronsard; Ashraf S Yousif; Janani Ramesh; N Sumi; Matthew Gorman; Vishnampettai G Ramachandran; Akhil C Banerjea Journal: Viruses Date: 2019-10-23 Impact factor: 5.048